reports
Trading by management and close relations of management
Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B in the attached file. Investor Relations Tobias Bjorklund Anders Enevoldsen Disa Tuominen Attachment
- Jesper Ingildsen
Royal Unibrew (Buy, TP: DKK625.00) - In a position of strength
Yesterday we attended Royal Unibrew’s CMD in the Netherlands. We found the event informative, especially about recent years’ acquisitions in Norway and the Netherlands. Our impression was that momentum is strong, and that the recent long-term organic EBIT target of 6–8% growth could be conservative. Following years of headwinds, the company seems to be emerging in a stronger position than ever. We reiterate our BUY and DKK625 target price.
Carlsberg AS: 1 director
A director at Carlsberg AS sold 13,517 shares at 941.660DKK and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
- ABGSC Food & Beverage Research
- Peter Sehested
Launch of Long-Term Incentive Plan for executive management and key em...
Launch of Long-Term Incentive Plan for executive management and key employees COMPANY ANNOUNCEMENT NO 14/2024 – MAY 13, 2024 Royal Unibrew A/S launches a new share based Long-Term Incentive Plan (LTIP) for selected key employees for 2024 designed to align the interests of Royal Unibrew’s employees and shareholders and to retain employees. The new LTIP for 2024 has been approved by the Board of Directors. The LTIP is based on Performance Share Units (PSU) granted to each key employee. The PSUs are granted in 2024 for vesting on the date the Board of Directors approves and makes public the ...
- ABGSC Food & Beverage Research
- Peter Sehested
Q1 update: Novonesis delivers 4% organic sales growth in line with exp...
Q1 update: Novonesis delivers 4% organic sales growth in line with expectations and reports progress on the integration For the first quarter as Novonesis, the company delivers 4% organic sales growth in line with expectations. Novonesis maintains the 2024 outlook of 5-7% organic sales growth with an adjusted EBITDA margin of around 35%. COPENHAGEN, Denmark – May 3, 2024. In the first three months of the 2024 financial year, Novonesis delivers 4% organic sales growth against a strong comparator. The organic sales growth in the first quarter is driven by both Food & Health Biosolution...
Trading statement Q1 2024
Trading statement Q1 2024 Novonesis realized 4% organic sales growth in line with expectations and maintains 2024 outlook. Ester Baiget, President & CEO: “I am pleased with the first quarter organic sales growth of 4% with growth in both Food & Health and Planetary Health. We are off to a good start in line with expectations and very well on track to deliver 5-7% organic sales growth for the full year with an adjusted EBITDA margin of around 35%. It’s highly comforting to see our new organization’s focus on both short and long-term deliverables and developments.” Pro forma sales perfo...
Annual General Meeting 2024
Annual General Meeting 2024 COMPANY ANNOUNCEMENT NO 13/2024 - May 1, 2024 On Tuesday, 30 April 2024 at 4 pm CEST Royal Unibrew A/S held its Annual General Meeting at which the below resolutions were adopted. Agenda and full contents of the proposals: 1. Report on the Company’s business activities during the yearThe Board of Directors’ report was noted. 2. Presentation of the audited Annual Report for 2023 for approval The Company’s Annual Report for 2023 was adopted by the Annual General Meeting. 3. Resolution to discharge the Board of Directors and the Execu...
- ABGSC Services Research
- Ali Shemmari
- Petter Nystrøm
- ABGSC Food & Beverage Research
- Peter Sehested
- Ole Martin Westgaard
- Jesper Ingildsen
Carlsberg (Buy, TP: DKK1110.00) - Solid start to the year
Overall, we consider the Q1 results a solid start to the year, with China’s and the premium beer momentum especially encouraging and supporting our view that the unchanged 2024 guidance looks conservative. We see room for positive earnings momentum throughout the year, with good weather providing upside potential. We thus reiterate our BUY and DKK1,110 target price.
Resolutions from the annual shareholders’ meeting 2024
Resolutions from the annual shareholders’ meeting 2024 Today an ordinary shareholders’ meeting was conducted. The following resolutions were made:• Approval of the audited Annual Report for 2023• Approval of distribution of profit with payment of an ordinary dividend of DKK 2.00 or EUR 0.27 per A/B share of DKK 2 for the last four months (September 1 - December 31) of 2023. Legacy Novozymes shareholders will then have received a total pay-out of the 2023 adjusted net profit of DKK 6.20 per share, which equals an increase of 3% compared with 2022.• Approval of the Remuneration Report fo...
- ABGSC Food & Beverage Research
- Peter Sehested
- Jesper Ingildsen
Royal Unibrew (Buy, TP: DKK625.00) - An early spring
Last night Royal Unibrew reported Q1 results early and raised its 2024 guidance due to efficiency improvements and acquisition-related benefits being achieved ahead of plan. This was a much-needed announcement considering the number of negative earnings revisions and market concerns related to the recent acquisitions. We reiterate our BUY and have raised our target price to DKK625 (600).
Q1 2024 Trading Statement
Q1 2024 Trading Statement COMPANY ANNOUNCEMENT NO 12/2024 - April 18, 2024 Strong business momentum continued into 2024 – organic EBIT growth guidance raised Statement by Royal Unibrew’s CEO, Lars Jensen: “The first quarter has marked a strong start to the year. The business momentum we built throughout 2023 has continued into 2024. The continued strong performance of our markets in Northern Europe, combined with a normalized Italian On-Trade beer channel and a strong rebound in our International segment, drove solid organic volume growth of 6% in the first quarter. Stron...
- Jesper Ingildsen
Royal Unibrew (Buy, TP: DKK600.00) - Solid start to the year
We expect Royal Unibrew to have a solid start to the year from a top-line perspective, while profitably is likely to be subdued due to revaluation of inventories when it reports Q1 results (due in the afternoon on 30 April). Despite our view that organic EBIT growth in Q1e will be below the 2024 guidance, Q1 is typically a small quarter and with profitability set to pick up throughout the year, we expect the guidance to be maintained. We reiterate our BUY and DKK600 target price.
- Jesper Ingildsen
Carlsberg (Buy, TP: DKK1110.00) - Probably a good start to the year
We expect the Q1 results to show Carlsberg had a good start to the year (due at 07:30 CET on 30 April). Slightly above consensus, we forecast c2% volume growth YOY and c6% organic revenue growth. Given Q1 is seasonally a small quarter, we believe the FY guidance could be kept for now, but that it remains conservative as usual, and see room for increases during the year. We reiterate our BUY and DKK1,110 target price.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.